These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 322921)

  • 61. A centrally mediated peripheral hypotensive effect of alpha-methyldopa.
    Ingenito AJ; Barrett JP; Procita L
    J Pharmacol Exp Ther; 1970 Dec; 175(3):593-9. PubMed ID: 5489916
    [No Abstract]   [Full Text] [Related]  

  • 62. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased metabolic heat production following chronic alpha-methyldopa therapy in hypertensives.
    Fernandez PG; Snedden W; Snellen JW; Galway AB; Nath C
    Can J Physiol Pharmacol; 1986 Feb; 64(2):138-44. PubMed ID: 3697832
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methyldopa and propranolol or practolol in moderate hypertension.
    Petrie JC; Galloway DB; Jeffers TA; Millar HR; Smith MC; Wood RA; Lewis JA; Simpson WT
    Br Med J; 1976 Jul; 2(6028):137-9. PubMed ID: 776350
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of bromocriptine in methyldopa treated hypertension.
    Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The mechanism of the antihypertensive action of -methyldopa in hypertensive rats.
    Day MD; Roach AG; Whiting RL
    Eur J Pharmacol; 1973 Mar; 21(3):271-80. PubMed ID: 4196583
    [No Abstract]   [Full Text] [Related]  

  • 67. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
    Fernandez PG; Zachariah PK; Bryant DG; Missan SS
    Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of alpha-methyldopa on renal function in hypertensive patients.
    Mohammed S; Hanenson IB; Magenheim HG; Gaffney TE
    Am Heart J; 1968 Jul; 76(1):21-7. PubMed ID: 4872981
    [No Abstract]   [Full Text] [Related]  

  • 69. Prazosin in hypertension with and without methyldopa.
    Kochar MS; Zeller JR; Itskovitz HD
    Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Crossover comparison of sotalol plus methyldopa in hypertension.
    Scrazzolo JE; Queirol AG
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):540-6. PubMed ID: 385637
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.
    Elliott HL; Whiting B; Reid JL
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):323S-328S. PubMed ID: 6824563
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alpha-methyldopa-chlorpromazine combination in schizophrenic patients.
    Chouinard G; Annable L
    Neuropsychobiology; 1976; 2(2-3):118-26. PubMed ID: 796755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Central cardiovascular effects of L-DOPA and clonidine in the lizard, Agama caudospinosa.
    Johansson P
    Acta Physiol Scand; 1982 Sep; 116(1):37-40. PubMed ID: 7158390
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhancement of the anti-hypertensive effect of methyldopa and other anti-hypertensive drugs by carbidopa in spontaneously hypertensive rats.
    Scriabine A; Ludden CT; Stone CA; Wurtman RJ; Watkins CJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():407s-410s. PubMed ID: 1071655
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ethanol, levodopa and inhibitors of extracerebral aromatic L-amino acid decarboxylase: a drug-drug interaction study.
    Messiha FS
    Proc West Pharmacol Soc; 1977; 20():327-31. PubMed ID: 896840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.